Anti-human F3 / CD142 monoclonal antibody, tisotumab biosimilar

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1070-100ug

  • Size

    100ug

  • Price

    $350

1
This antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
note Other commonly used names in publications refering to this antibody: HuMax-TF
target F3 / CD142
alias Tissue factor, TF, F3, Thromboplastin, Coagulation factor III
gene id Uniprot ID: P13726
host species Human
reactivity Human
iso type Human IgG1 kappa
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml
applications ELISA, Flow Cyt
dilution ELISA 1:5000-10000, Flow Cyt 1:100
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.

Images

ELISA plate pre-coated by 2 ug/mL (100 uL/well) Human CD142 Protein, hFc Tag binds to Anti-CD142 Neutralizing antibody in a linear range of 2.93?187.50 ng/mL.

Flow cytometry analysis of antigen binding of anti-human CD142 mAb. (A) The antibody does not bind to CHO-S cells that do not express CD142. (B) A clear peak shift of The antibody was seen compared to the control when incubated with CD142-expressing Hela cells, indicating strong binding of The antibody to CD142. Antibodies were incubated at 5 ug/mL.


PRODUCT

  • SKU

    DMS1070-100ug

  • Size

    100ug

  • Price

    $350

1